Cargando…

ErBb Family Proteins in Cholangiocarcinoma and Clinical Implications

The erythroblastic leukemia viral oncogene homolog (ErBb) family consists of the receptor tyrosine kinases (RTK) epidermal growth factor receptor (EGFR; also called ERBB1), ERBB2, ERBB3, and ERBB4. This family is closely associated with the progression of cholangiocarcinoma (CC) through the regulati...

Descripción completa

Detalles Bibliográficos
Autor principal:	Jin, Wook
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7408920/ https://www.ncbi.nlm.nih.gov/pubmed/32708604 http://dx.doi.org/10.3390/jcm9072255

Ejemplares similares

Neuregulin4 Acts on Hypothalamic ErBb4 to Excite Oxytocin Neurons and Preserve Metabolic Homeostasis
por: Zhang, Yi, et al.
Publicado: (2023)

Genomic alterations of ERBB receptors in cancer: clinical implications
por: Mishra, Rosalin, et al.
Publicado: (2017)

The role and implication of autophagy in cholangiocarcinoma
por: Khizar, Hayat, et al.
Publicado: (2023)

Fulvestrant-induced expression of erbB3 and erbB4 sensitizes ER-positive breast cancer cells to heregulins
por: Hutcheson, IR, et al.
Publicado: (2010)

Serum and tissue markers in hepatocellular carcinoma and cholangiocarcinoma: clinical and prognostic implications
por: Berretta, Massimiliano, et al.
Publicado: (2016)

Regulation of Src Family Kinases during Colorectal Cancer Development and Its Clinical Implications
por: Jin, Wook
Publicado: (2020)

Targeting ERBB2 mutations in solid tumors: biological and clinical implications
por: Cousin, Sophie, et al.
Publicado: (2018)

ErbB Family Signalling: A Paradigm for Oncogene Addiction and Personalized Oncology
por: Jacobi, Nico, et al.
Publicado: (2017)

The characterization, management, and future considerations for ErbB-family TKI-associated diarrhea
por: Rugo, Hope S., et al.
Publicado: (2019)

Trastuzumab and pertuzumab in circulating tumor DNA ERBB2-amplified HER2-positive refractory cholangiocarcinoma
por: Yarlagadda, Bhavya, et al.
Publicado: (2019)

ErbB2 Is Necessary for Induction of Carcinoma Cell Invasion by Erbb Family Receptor Tyrosine Kinases
por: Spencer, Kathryn S.R., et al.
Publicado: (2000)

Role of Cancer Stem Cells in Cholangiocarcinoma and Therapeutic Implications
por: Wu, Hsing-Ju, et al.
Publicado: (2019)

Implication of Ferroptosis in Cholangiocarcinoma: A Potential Future Target?
por: Yang, Mingyu, et al.
Publicado: (2023)

Search for the radion decay into a Higgs boson pair with $\gamma\gamma +bb, \tau\tau+bb$ and $bb+bb$ final states
por: Gennai, Simone
Publicado: (2004)

Tyrosine kinase signalling in breast cancer: ErbB family receptor tyrosine kinases
por: Stern, David F
Publicado: (2000)

In Utero Exposure to Bisphenol a Promotes Mammary Tumor Risk in MMTV-Erbb2 Transgenic Mice Through the Induction of ER-erbB2 Crosstalk
por: Ma, Zhikun, et al.
Publicado: (2020)

Clinical Significance of ErbB Receptor Family in Urothelial Carcinoma of the Bladder: A Systematic Review and Meta-Analysis
por: Tsai, Yuh-Shyan, et al.
Publicado: (2012)

Sequence Variation and Expression of the Gimap Gene Family in the BB Rat
por: Rutledge, Elizabeth A., et al.
Publicado: (2009)

Phosphotyrosine interactome of the ErbB-receptor kinase family
por: Schulze, Waltraud X, et al.
Publicado: (2005)

Clinical Impact of Sarcopenia on Cholangiocarcinoma
por: Shin, Suk-Pyo, et al.
Publicado: (2022)

bbH
por: Asawatangtrakuldee, Chayanit
Publicado: (2022)

A comprehensive review of the preclinical efficacy profile of the ErbB family blocker afatinib in cancer
por: Modjtahedi, Helmout, et al.
Publicado: (2014)

Germline ERBB3 mutation in familial non-small-cell lung carcinoma: expanding ErbB’s role in oncogenesis
por: McInerney-Leo, Aideen M, et al.
Publicado: (2021)

The clinical implications and molecular features of intrahepatic cholangiocarcinoma with perineural invasion
por: Meng, Xian-Long, et al.
Publicado: (2022)

Regulation of ErbB Receptors by the Ca(2+) Sensor Protein Calmodulin in Cancer
por: Villalobo, Antonio
Publicado: (2023)

Analysis of Somatic Mutations in Cancer: Molecular Mechanisms of Activation in the ErbB Family of Receptor Tyrosine Kinases
por: Shih, Andrew J., et al.
Publicado: (2011)

Molecularly targeted therapy for the treatment of head and neck cancer: a review of the ErbB family inhibitors
por: Sacco, Assuntina G, et al.
Publicado: (2016)

The focus clinical research in intrahepatic cholangiocarcinoma
por: Song, Yinghui, et al.
Publicado: (2022)

ErbB Proteins as Molecular Target of Dietary Phytochemicals in Malignant Diseases
por: Filippi, Alexandru, et al.
Publicado: (2017)

Negative regulation of ErbB family receptor tyrosine kinases
por: Sweeney, C, et al.
Publicado: (2004)

Cancer-Associated Fibroblasts in Cholangiocarcinoma: Current Knowledge and Possible Implications for Therapy
por: Montori, Michele, et al.
Publicado: (2022)

ER Stress-Sensor Proteins and ER-Mitochondrial Crosstalk—Signaling Beyond (ER) Stress Response
por: Kumar, Vaishali, et al.
Publicado: (2021)

Tumor Microenvironment and its Implications for Antitumor Immunity in Cholangiocarcinoma: Future Perspectives for Novel Therapies
por: Cao, Hengsong, et al.
Publicado: (2022)

Modulation of ErbB2 Blockade in ErbB2-Positive Cancers: The Role of ErbB2 Mutations and PHLDA1
por: Li, Guangyuan, et al.
Publicado: (2014)

Cholangiocarcinoma
por: Sarcognato, Samantha, et al.
Publicado: (2021)

ER-to-Golgi Trafficking and Its Implication in Neurological Diseases
por: Wang, Bo, et al.
Publicado: (2020)

Locoregional Treatments in Cholangiocarcinoma and Combined Hepatocellular Cholangiocarcinoma
por: Renzulli, Matteo, et al.
Publicado: (2021)

The Bb real book.
Publicado: (2009)

ATLAS H(bb)
por: Scanlon, Tim
Publicado: (2017)

Higgs to bb in ATLAS
por: Lee, J S H
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_1r4j423m013k63cc21nk4ui8h4